Clinical Trials Logo

Vitrectomy clinical trials

View clinical trials related to Vitrectomy.

Filter by:

NCT ID: NCT02210481 Completed - Vitrectomy Clinical Trials

The Role of Intravitreal Glucose in Macular Thinning Following Surgery for Retinal Detachment or Epimacular Membrane

GLU-MAC
Start date: February 2014
Phase: N/A
Study type: Observational

Comparison between intravitreous glucose rate and macular thinning measured by Ocular Coherence Tomography (OCT) at 3 months post vitrectomy for retinal detachment or epimacular membrane. Hypothesis : Association between post-operative macular thickness and intravitreous glucose rate

NCT ID: NCT01319318 Completed - Vitrectomy Clinical Trials

Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy

Start date: March 2011
Phase: N/A
Study type: Observational

This study will evaluate the degree of post-operative ocular inflammation in patients who are undergoing a pars plana vitrectomy.

NCT ID: NCT01255293 Completed - Clinical trials for Diabetic Retinopathy

Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments

Start date: November 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the retinal redetachment rates with 1000 centistoke versus 5000 centistoke silicone oil tamponade for repair of complex retinal detachments.

NCT ID: NCT01229410 Completed - Vitrectomy Clinical Trials

Pharmacokinetics of the Brimonidine Tartrate Posterior Segment Delivery System in Patients Undergoing Pars Plana Vitrectomy

Start date: December 2010
Phase: Phase 1
Study type: Interventional

This study will evaluate the pharmacokinetics of brimonidine following a single intravitreal administration of the 200 ug or 400 ug Brimonidine Tartrate Posterior Segment Drug Delivery System in patients 2, 4 or 8 weeks prior to undergoing a pars plana vitrectomy.

NCT ID: NCT01176331 Completed - Vitrectomy Clinical Trials

Outcomes of 20 and 23-gauge Combined Transconjunctival Pars Plana Vitrectomy

Start date: n/a
Phase: Phase 4
Study type: Observational

In a retrospective study, a combined 20 and 23-gauge pars plana vitrectomy procedure was performed in 21 eyes for various indications and proposed as a transition procedure to 23-gauge transconjunctival vitrectomy. Through use of combination of procedures postoperative complications, surgical trauma and healing time was decreased; operating time was reduced; costs were decreased.

NCT ID: NCT01159665 Completed - Vitrectomy Clinical Trials

The Purpose of This Study is to Evaluate the Pharmacokinetic Properties of Intravitreal Ocriplasmin Prior to Planned Primary Pars Plana Vitrectomy (PPV)

MIVI-10
Start date: July 2010
Phase: Phase 2
Study type: Interventional

To evaluate the pharmacokinetic properties of intravitreal ocriplasmin 125 µg dose when administered at different time-points prior to planned primary pars plana vitrectomy (PPV)

NCT ID: NCT01051648 Completed - Cataract Clinical Trials

Triamcinolone Assisted Anterior Vitrectomy

Start date: December 2007
Phase: Phase 2
Study type: Interventional

Injecting Triamcinolone acetenoide for visualizing and removing vitreous from the anterior chamber.

NCT ID: NCT01023009 Recruiting - Vitrectomy Clinical Trials

Postoperative Evolution After Small Gauge Vitrectomy Without Eye Occlusion

Vitrectomy
Start date: May 2009
Phase: N/A
Study type: Observational

After an uneventfully small gauge vitrectomy we don´t think is necessary to occlude the eye for 24 hours

NCT ID: NCT00986362 Completed - Vitrectomy Clinical Trials

Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy

MIC
Start date: February 2010
Phase: Phase 2
Study type: Interventional

To evaluate the safety and preliminary efficacy of intravitreal microplasmin as an adjunct to conventional vitrectomy for the treatment of pediatric patients.

NCT ID: NCT00927628 Completed - Vitrectomy Clinical Trials

Macular Hole Reopening

Start date: October 1990
Phase: N/A
Study type: Observational

The purpose of this investigation was to determine the incidence and the factors that cause a reopening of a macular hole (MH) after a surgical closure.